HRS-7249

· Fujian Shengdi Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HRS-7249, covering 2025-09-10 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis [Phase 2]

See pricing